Calcium in PDB 4qd2: Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex
Protein crystallography data
The structure of Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex, PDB code: 4qd2
was solved by
K.Lee,
X.Zhong,
S.Gu,
A.Kruel,
M.B.Dorner,
K.Perry,
A.Rummel,
M.Dong,
R.Jin,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
47.73 /
2.40
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
86.990,
95.730,
96.140,
116.89,
96.34,
93.70
|
R / Rfree (%)
|
20.8 /
24.7
|
Calcium Binding Sites:
The binding sites of Calcium atom in the Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex
(pdb code 4qd2). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 6 binding sites of Calcium where determined in the
Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex, PDB code: 4qd2:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
Calcium binding site 1 out
of 6 in 4qd2
Go back to
Calcium Binding Sites List in 4qd2
Calcium binding site 1 out
of 6 in the Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Ca301
b:44.0
occ:1.00
|
OE1
|
E:GLU69
|
2.3
|
51.3
|
1.0
|
OD1
|
E:ASP67
|
2.3
|
46.3
|
1.0
|
OD2
|
E:ASP103
|
2.3
|
42.2
|
1.0
|
OE1
|
E:GLU11
|
2.4
|
32.9
|
1.0
|
O
|
E:HOH430
|
3.0
|
40.2
|
1.0
|
O
|
E:HOH417
|
3.1
|
40.7
|
1.0
|
CG
|
E:ASP103
|
3.1
|
40.8
|
1.0
|
OD1
|
E:ASP103
|
3.3
|
41.6
|
1.0
|
CG
|
E:ASP67
|
3.3
|
47.3
|
1.0
|
CD
|
E:GLU11
|
3.4
|
34.8
|
1.0
|
CD
|
E:GLU69
|
3.4
|
47.5
|
1.0
|
CA
|
E:CA302
|
3.8
|
36.2
|
1.0
|
OE2
|
E:GLU11
|
3.9
|
36.4
|
1.0
|
OD2
|
E:ASP67
|
4.0
|
49.2
|
1.0
|
ND2
|
E:ASN104
|
4.1
|
39.7
|
1.0
|
OE2
|
E:GLU69
|
4.1
|
48.0
|
1.0
|
N
|
E:ARG68
|
4.2
|
39.5
|
1.0
|
OD1
|
E:ASN12
|
4.3
|
35.4
|
1.0
|
CB
|
E:ASP67
|
4.3
|
43.8
|
1.0
|
CA
|
E:ASP67
|
4.3
|
41.8
|
1.0
|
N
|
E:GLU69
|
4.4
|
42.6
|
1.0
|
O
|
E:HOH429
|
4.4
|
42.7
|
1.0
|
CG
|
E:GLU69
|
4.4
|
46.7
|
1.0
|
CB
|
E:GLU69
|
4.5
|
46.2
|
1.0
|
C
|
E:ASP67
|
4.5
|
39.1
|
1.0
|
CG
|
E:GLU11
|
4.6
|
34.8
|
1.0
|
CB
|
E:ASP103
|
4.6
|
38.6
|
1.0
|
ND2
|
E:ASN12
|
4.6
|
33.0
|
1.0
|
O
|
E:HOH434
|
4.8
|
47.8
|
1.0
|
CB
|
E:GLU11
|
4.9
|
36.9
|
1.0
|
CG
|
E:ASN12
|
4.9
|
33.7
|
1.0
|
|
Calcium binding site 2 out
of 6 in 4qd2
Go back to
Calcium Binding Sites List in 4qd2
Calcium binding site 2 out
of 6 in the Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Ca302
b:36.2
occ:1.00
|
OD1
|
E:ASP100
|
2.3
|
38.6
|
1.0
|
OE2
|
E:GLU69
|
2.3
|
48.0
|
1.0
|
OD1
|
E:ASP103
|
2.3
|
41.6
|
1.0
|
O
|
E:GLN101
|
2.4
|
31.7
|
1.0
|
OD1
|
E:ASP136
|
2.5
|
47.3
|
1.0
|
OE2
|
E:GLU11
|
2.5
|
36.4
|
1.0
|
CD
|
E:GLU69
|
3.0
|
47.5
|
1.0
|
OE1
|
E:GLU69
|
3.2
|
51.3
|
1.0
|
CG
|
E:ASP103
|
3.3
|
40.8
|
1.0
|
CD
|
E:GLU11
|
3.4
|
34.8
|
1.0
|
CG
|
E:ASP136
|
3.4
|
44.8
|
1.0
|
CG
|
E:ASP100
|
3.4
|
41.8
|
1.0
|
OE1
|
E:GLU11
|
3.6
|
32.9
|
1.0
|
C
|
E:GLN101
|
3.6
|
34.1
|
1.0
|
ND2
|
E:ASN104
|
3.8
|
39.7
|
1.0
|
CA
|
E:CA301
|
3.8
|
44.0
|
1.0
|
N
|
E:GLN101
|
3.9
|
36.6
|
1.0
|
OD2
|
E:ASP103
|
3.9
|
42.2
|
1.0
|
OD2
|
E:ASP100
|
4.0
|
41.2
|
1.0
|
N
|
E:ASP103
|
4.0
|
33.7
|
1.0
|
CB
|
E:ASP136
|
4.1
|
43.5
|
1.0
|
OD2
|
E:ASP136
|
4.2
|
45.1
|
1.0
|
CA
|
E:ASP136
|
4.3
|
43.1
|
1.0
|
CA
|
E:GLN101
|
4.3
|
35.8
|
1.0
|
CG
|
E:GLU69
|
4.4
|
46.7
|
1.0
|
NE
|
E:ARG68
|
4.4
|
43.6
|
1.0
|
CB
|
E:ASP103
|
4.5
|
38.6
|
1.0
|
CB
|
E:ASP100
|
4.6
|
44.2
|
1.0
|
N
|
E:ASN102
|
4.7
|
34.4
|
1.0
|
CA
|
E:ASP100
|
4.7
|
43.4
|
1.0
|
CA
|
E:ASP103
|
4.7
|
36.4
|
1.0
|
C
|
E:ASP100
|
4.7
|
41.2
|
1.0
|
NH2
|
E:ARG68
|
4.8
|
45.6
|
1.0
|
CG
|
E:GLU11
|
4.8
|
34.8
|
1.0
|
CA
|
E:ASN102
|
4.8
|
34.0
|
1.0
|
N
|
E:ASN104
|
4.9
|
40.6
|
1.0
|
CB
|
E:GLN101
|
4.9
|
35.7
|
1.0
|
C
|
E:ASN102
|
4.9
|
35.0
|
1.0
|
CG
|
E:ASN104
|
5.0
|
40.6
|
1.0
|
|
Calcium binding site 3 out
of 6 in 4qd2
Go back to
Calcium Binding Sites List in 4qd2
Calcium binding site 3 out
of 6 in the Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
E:Ca303
b:42.0
occ:1.00
|
OD2
|
E:ASP134
|
2.3
|
42.1
|
1.0
|
O
|
E:ASN143
|
2.4
|
37.6
|
1.0
|
OD2
|
E:ASP136
|
2.4
|
45.1
|
1.0
|
O
|
E:ASN104
|
2.4
|
45.6
|
1.0
|
OD2
|
E:ASP195
|
2.4
|
34.4
|
1.0
|
OD1
|
E:ASN102
|
2.4
|
31.9
|
1.0
|
OD1
|
E:ASP134
|
2.5
|
41.5
|
1.0
|
CG
|
E:ASP134
|
2.7
|
42.1
|
1.0
|
CG
|
E:ASP195
|
3.3
|
33.0
|
1.0
|
CG
|
E:ASP136
|
3.4
|
44.8
|
1.0
|
C
|
E:ASN143
|
3.5
|
37.9
|
1.0
|
C
|
E:ASN104
|
3.6
|
44.4
|
1.0
|
CG
|
E:ASN102
|
3.6
|
36.0
|
1.0
|
CB
|
E:ASP136
|
3.8
|
43.5
|
1.0
|
CB
|
E:ASP195
|
3.8
|
29.4
|
1.0
|
CB
|
E:ASP134
|
4.2
|
42.0
|
1.0
|
N
|
E:ASN104
|
4.3
|
40.6
|
1.0
|
CA
|
E:ASN104
|
4.3
|
41.2
|
1.0
|
ND2
|
E:ASN102
|
4.3
|
28.6
|
1.0
|
OD1
|
E:ASP195
|
4.3
|
33.7
|
1.0
|
CB
|
E:ASN104
|
4.4
|
40.3
|
1.0
|
OD1
|
E:ASP136
|
4.4
|
47.3
|
1.0
|
CA
|
E:ASN143
|
4.4
|
39.6
|
1.0
|
CB
|
E:ASN143
|
4.4
|
39.1
|
1.0
|
N
|
E:ALA144
|
4.5
|
37.3
|
1.0
|
CA
|
E:ALA144
|
4.6
|
34.4
|
1.0
|
CD
|
E:PRO106
|
4.6
|
43.3
|
1.0
|
N
|
E:ARG105
|
4.6
|
44.8
|
1.0
|
N
|
E:ASP136
|
4.8
|
40.0
|
1.0
|
CB
|
E:ASN102
|
4.8
|
34.7
|
1.0
|
CA
|
E:ASN102
|
4.8
|
34.0
|
1.0
|
N
|
E:PRO106
|
4.9
|
43.7
|
1.0
|
CA
|
E:ARG105
|
4.9
|
44.2
|
1.0
|
C
|
E:ASN102
|
4.9
|
35.0
|
1.0
|
C
|
E:ARG105
|
4.9
|
42.0
|
1.0
|
CA
|
E:ASP136
|
4.9
|
43.1
|
1.0
|
|
Calcium binding site 4 out
of 6 in 4qd2
Go back to
Calcium Binding Sites List in 4qd2
Calcium binding site 4 out
of 6 in the Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
J:Ca301
b:45.5
occ:1.00
|
OD2
|
J:ASP103
|
2.3
|
46.0
|
1.0
|
OD1
|
J:ASP67
|
2.3
|
47.3
|
1.0
|
OE1
|
J:GLU69
|
2.3
|
36.1
|
1.0
|
OE1
|
J:GLU11
|
2.4
|
41.2
|
1.0
|
CG
|
J:ASP103
|
3.1
|
43.3
|
1.0
|
OD1
|
J:ASP103
|
3.2
|
43.0
|
1.0
|
CG
|
J:ASP67
|
3.4
|
47.8
|
1.0
|
CD
|
J:GLU11
|
3.4
|
43.3
|
1.0
|
CD
|
J:GLU69
|
3.5
|
37.1
|
1.0
|
CA
|
J:CA302
|
3.8
|
39.0
|
1.0
|
OE2
|
J:GLU11
|
3.9
|
45.2
|
1.0
|
OD2
|
J:ASP67
|
4.2
|
49.6
|
1.0
|
ND2
|
J:ASN104
|
4.2
|
40.5
|
1.0
|
CB
|
J:GLU69
|
4.3
|
41.5
|
1.0
|
CG
|
J:GLU69
|
4.3
|
38.5
|
1.0
|
OD1
|
J:ASN12
|
4.3
|
40.8
|
1.0
|
CB
|
J:ASP67
|
4.4
|
46.9
|
1.0
|
N
|
J:GLU69
|
4.4
|
45.0
|
1.0
|
N
|
J:ARG68
|
4.4
|
46.1
|
1.0
|
ND2
|
J:ASN12
|
4.4
|
40.7
|
1.0
|
CB
|
J:ASP103
|
4.4
|
40.0
|
1.0
|
OE2
|
J:GLU69
|
4.5
|
39.1
|
1.0
|
CA
|
J:ASP67
|
4.5
|
47.9
|
1.0
|
CG
|
J:GLU11
|
4.7
|
44.3
|
1.0
|
C
|
J:ASP67
|
4.8
|
48.1
|
1.0
|
CG
|
J:ASN12
|
4.8
|
40.2
|
1.0
|
|
Calcium binding site 5 out
of 6 in 4qd2
Go back to
Calcium Binding Sites List in 4qd2
Calcium binding site 5 out
of 6 in the Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
J:Ca302
b:39.0
occ:1.00
|
OD1
|
J:ASP100
|
2.3
|
48.4
|
1.0
|
OD1
|
J:ASP136
|
2.4
|
46.2
|
1.0
|
OD1
|
J:ASP103
|
2.4
|
43.0
|
1.0
|
OE2
|
J:GLU69
|
2.4
|
39.1
|
1.0
|
OE2
|
J:GLU11
|
2.4
|
45.2
|
1.0
|
OE1
|
J:GLU69
|
2.5
|
36.1
|
1.0
|
O
|
J:GLN101
|
2.5
|
47.2
|
1.0
|
CD
|
J:GLU69
|
2.8
|
37.1
|
1.0
|
CD
|
J:GLU11
|
3.4
|
43.3
|
1.0
|
CG
|
J:ASP103
|
3.4
|
43.3
|
1.0
|
CG
|
J:ASP136
|
3.5
|
45.1
|
1.0
|
CG
|
J:ASP100
|
3.5
|
48.2
|
1.0
|
OE1
|
J:GLU11
|
3.6
|
41.2
|
1.0
|
ND2
|
J:ASN104
|
3.7
|
40.5
|
1.0
|
C
|
J:GLN101
|
3.7
|
46.6
|
1.0
|
CA
|
J:CA301
|
3.8
|
45.5
|
1.0
|
OD2
|
J:ASP103
|
3.8
|
46.0
|
1.0
|
N
|
J:GLN101
|
4.0
|
44.9
|
1.0
|
OD2
|
J:ASP100
|
4.0
|
47.9
|
1.0
|
N
|
J:ASP103
|
4.1
|
39.6
|
1.0
|
CG
|
J:GLU69
|
4.2
|
38.5
|
1.0
|
CB
|
J:ASP136
|
4.2
|
43.0
|
1.0
|
CA
|
J:ASP136
|
4.3
|
45.5
|
1.0
|
OD2
|
J:ASP136
|
4.3
|
49.1
|
1.0
|
NE
|
J:ARG68
|
4.4
|
47.1
|
1.0
|
CA
|
J:GLN101
|
4.4
|
47.5
|
1.0
|
CB
|
J:ASP103
|
4.6
|
40.0
|
1.0
|
CB
|
J:ASP100
|
4.7
|
46.4
|
1.0
|
CG
|
J:GLU11
|
4.7
|
44.3
|
1.0
|
CA
|
J:ASP100
|
4.8
|
46.2
|
1.0
|
N
|
J:ASN102
|
4.8
|
43.7
|
1.0
|
C
|
J:ASP100
|
4.8
|
46.6
|
1.0
|
CB
|
J:ARG68
|
4.8
|
43.9
|
1.0
|
CA
|
J:ASP103
|
4.8
|
39.3
|
1.0
|
CB
|
J:GLN101
|
4.9
|
48.8
|
1.0
|
CG
|
J:ASN104
|
4.9
|
42.5
|
1.0
|
CA
|
J:ASN102
|
5.0
|
41.7
|
1.0
|
NH2
|
J:ARG68
|
5.0
|
45.9
|
1.0
|
N
|
J:ASN104
|
5.0
|
37.4
|
1.0
|
|
Calcium binding site 6 out
of 6 in 4qd2
Go back to
Calcium Binding Sites List in 4qd2
Calcium binding site 6 out
of 6 in the Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
J:Ca303
b:45.9
occ:1.00
|
O
|
J:ASN143
|
2.3
|
49.8
|
1.0
|
OD2
|
J:ASP134
|
2.4
|
46.3
|
1.0
|
O
|
J:ASN104
|
2.4
|
44.3
|
1.0
|
OD1
|
J:ASP134
|
2.4
|
46.4
|
1.0
|
OD2
|
J:ASP136
|
2.4
|
49.1
|
1.0
|
OD2
|
J:ASP195
|
2.4
|
42.4
|
1.0
|
OD1
|
J:ASN102
|
2.4
|
40.3
|
1.0
|
CG
|
J:ASP134
|
2.7
|
46.6
|
1.0
|
CG
|
J:ASP136
|
3.4
|
45.1
|
1.0
|
CG
|
J:ASP195
|
3.4
|
43.8
|
1.0
|
C
|
J:ASN104
|
3.5
|
44.5
|
1.0
|
C
|
J:ASN143
|
3.5
|
52.0
|
1.0
|
CG
|
J:ASN102
|
3.6
|
39.7
|
1.0
|
CB
|
J:ASP136
|
3.7
|
43.0
|
1.0
|
CB
|
J:ASP195
|
3.8
|
43.4
|
1.0
|
CA
|
J:ASN104
|
4.2
|
40.4
|
1.0
|
CB
|
J:ASP134
|
4.2
|
47.3
|
1.0
|
N
|
J:ASN104
|
4.2
|
37.4
|
1.0
|
CB
|
J:ASN104
|
4.3
|
41.3
|
1.0
|
ND2
|
J:ASN102
|
4.3
|
39.3
|
1.0
|
OD1
|
J:ASP195
|
4.4
|
45.4
|
1.0
|
N
|
J:ALA144
|
4.4
|
53.5
|
1.0
|
CA
|
J:ASN143
|
4.5
|
51.5
|
1.0
|
OD1
|
J:ASP136
|
4.5
|
46.2
|
1.0
|
CA
|
J:ALA144
|
4.5
|
52.6
|
1.0
|
CB
|
J:ASN143
|
4.5
|
50.0
|
1.0
|
N
|
J:ARG105
|
4.6
|
48.3
|
1.0
|
CD
|
J:PRO106
|
4.7
|
52.4
|
1.0
|
CB
|
J:ASN102
|
4.8
|
40.1
|
1.0
|
CA
|
J:ASN102
|
4.8
|
41.7
|
1.0
|
N
|
J:ASP136
|
4.8
|
46.1
|
1.0
|
CD1
|
J:LEU201
|
4.9
|
38.4
|
1.0
|
CA
|
J:ASP136
|
4.9
|
45.5
|
1.0
|
CA
|
J:ARG105
|
4.9
|
50.9
|
1.0
|
C
|
J:ASN102
|
4.9
|
41.9
|
1.0
|
N
|
J:PRO106
|
5.0
|
52.8
|
1.0
|
C
|
J:ARG105
|
5.0
|
51.6
|
1.0
|
|
Reference:
K.Lee,
X.Zhong,
S.Gu,
A.M.Kruel,
M.B.Dorner,
K.Perry,
A.Rummel,
M.Dong,
R.Jin.
Molecular Basis For Disruption of E-Cadherin Adhesion By Botulinum Neurotoxin A Complex. Science V. 344 1405 2014.
ISSN: ISSN 0036-8075
PubMed: 24948737
DOI: 10.1126/SCIENCE.1253823
Page generated: Sun Jul 14 12:24:38 2024
|